Girindus America is hosting an Oligonucleotide Technical Symposium being held in conjunction with the inauguration of their new commercial scale oligonucleotide facility. This symposium is co-sponsored by the Genomics Research Institute and the Cincinnati chapter of the American Chemical Society. The Symposium will be March 9, 2005, at the Genomics Research Institute Auditorium in Cincinnati, […]
I thought I’d post an update since I was making a donation today and thinking about the victims of the tsunami. The American Red Cross today announced a massive relief plan for those affected by the tsunamis, requiring an estimated $400 million to respond to both immediate and long-term needs now and years into the […]
The New York Times ran an article promoting the idea of a risk-based protocol for safety evaluation that would greatly reduce the time and costs involved in developing most new gene-spliced crops. The author warns that alarmist warnings about the possible hazards of gene splicing have made the public extremely wary of this selective form […]
The USPTO announced the 2004 top 10 private sector patent recipients. Listed below are the 10 corporations receiving the most patents for inventions in 2004, along with their 2003 ranking. Note that tech companies continue to outpace any of the bio-pharma companies in patent filings given the number of big companies that have shrinking pipelines. […]
According to CXOToday, IBM today opened 500 key innovations to the Open Source community, believed to be the largest pledge ever of patents of any kind in the world. The pledge applies to any individual, community, or company working on or using software that meets the Open Source Initiative (OSI) definition of Open Source software. […]
Advanced Cell Technology, Inc. (ACT) announced today the intent to appeal the decision of the Board of Patent Appeals and Interference, interference number 104,746, between itself and Geron Corporation (Nasdaq:GERN) to the U.S. District Court. Advanced Cell Technology disputes Geron Corporation’s claim that ACT’s patent at issue in the interference has been invalidated. An issued […]
The USPTO’s Patent Application Information Retrieval (PAIR) sytem now lists expirations due to failure to pay maintenance fees. Expired patents now have a status of "Patent Expired Due to Non-Payment of Maintenance Fees Under 37 CFR 1.362". Patents can, of course, expire in other ways. If a patent is subject to a terminal disclaimer relative […]
The U.S. Supreme Court agreed to review a lower ruling in which a patent held by Integra LifeSciences Holdings prevented Germany’s Merck KGaA from conducting conduct "head-start" exploratory research for future applications into a potential new anticancer drug, even if the drug could not feasibly be marketed until after the patent expired in 2006. Under […]
Served Up Daily
Editor-in-Chief Barista Stephen Jenei is a patent attorney and Owner of Jenei LLC. When not serving up patent chat over a steaming cup of java, he's handling a diverse intellectual property practice in the biotechnology, pharmaceutical and chemical fields. More info @ Jenei LLC
